Pool size and the sustainability of optimal risk-sharing agreements

被引:0
|
作者
Francesca Barigozzi
Renaud Bourlès
Dominique Henriet
Giuseppe Pignataro
机构
[1] University of Bologna,Department of Economics
[2] Centrale Marseille (Aix-Marseille School of Economics),undefined
[3] CNRS & EHESS,undefined
来源
Theory and Decision | 2017年 / 82卷
关键词
Optimal risk-sharing agreement; Loss-mitigating actions; Repeated interactions; Collectively optimal vs Nash behaviors;
D O I
暂无
中图分类号
学科分类号
摘要
We study a risk-sharing agreement where members exert a loss-mitigating action which decreases the amount of reimbursements to be paid in the pool. The action is costly and members tend to free-ride on it. An optimal risk-sharing agreement maximizes the expected utility of a representative member with respect to both the coverage and the (collective) action such that efficiency is restored. We study the sustainability of the optimal agreement as equilibrium in a repeated game with indefinite number of repetitions. When the optimal agreement is not enforceable, the equilibrium with free-riding emerges. We identify an interesting trade-off: welfare generated by the optimal risk-sharing agreement increases with the size of the pool, but at the same time the pool size must not be too large for collective choices to be self-enforcing. This generates a discontinuous effect of pool size on welfare.
引用
收藏
页码:273 / 303
页数:30
相关论文
共 50 条
  • [1] Pool size and the sustainability of optimal risk-sharing agreements
    Barigozzi, Francesca
    Bourles, Renaud
    Henriet, Dominique
    Pignataro, Giuseppe
    THEORY AND DECISION, 2017, 82 (02) : 273 - 303
  • [2] Pharmaceutical Risk-Sharing Agreements
    Afschin Gandjour
    PharmacoEconomics, 2009, 27 : 431 - 432
  • [3] Pharmaceutical Risk-Sharing Agreements
    Joseph P. Cook
    John A. Vernon
    Richard Manning
    PharmacoEconomics, 2008, 26 : 551 - 556
  • [4] Pharmaceutical risk-sharing agreements
    Cook, Joseph P.
    Vernon, John A.
    Manning, Richard
    PHARMACOECONOMICS, 2008, 26 (07) : 551 - 556
  • [5] Pharmaceutical Risk-Sharing Agreements
    Gandjour, Afschin
    PHARMACOECONOMICS, 2009, 27 (05) : 431 - 432
  • [6] POTENTIAL RISK-SHARING AGREEMENTS FOR VACCINES
    Terlinden, A.
    Ethgen, O.
    Demarteau, N.
    Curran, D.
    VALUE IN HEALTH, 2014, 17 (07) : A669 - A670
  • [7] Where Are We on "Risk-Sharing" Agreements?
    Neumann, Peter J.
    VALUE IN HEALTH, 2013, 16 (05) : 701 - 702
  • [8] Risk-sharing agreements, present and future
    Goncalves, Francisco R.
    Santos, Susana
    Silva, Catarina
    Sousa, Gabriela
    ECANCERMEDICALSCIENCE, 2018, 12
  • [9] Italian risk-sharing agreements on drugs: are they worthwhile?
    Livio Garattini
    Alessandro Curto
    Katelijne van de Vooren
    The European Journal of Health Economics, 2015, 16 : 1 - 3
  • [10] Insurance-based risk-sharing agreements
    Augustin Terlinden
    Amine Aissaoui
    Olivier Ethgen
    Journal of Pharmaceutical Policy and Practice, 8 (Suppl 1)